These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 3915142

  • 1. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Campino C, Pumarino H, Michelsen H, Piraino P, Generini G, Bruggendieck B.
    Rev Med Chil; 1985 Apr; 113(4):296-300. PubMed ID: 3915142
    [No Abstract] [Full Text] [Related]

  • 2. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
    Felt V, Nedvídková J, Krejcík L, Hainer V.
    Cas Lek Cesk; 1977 May 13; 116(19):591-4. PubMed ID: 406999
    [No Abstract] [Full Text] [Related]

  • 3. [Response of growth hormone (HGH) to L-dopa, L-arginine and their combination in normal individuals].
    Hernández Armas J, González García C, Rodríguez I.
    Med Clin (Barc); 1977 May 13; 79(8):365-9. PubMed ID: 6757593
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative action of L-dopa and bromocriptine on thyreostimulating hormone (T.S.H.) in primary hypothyroïdism (author's transl)].
    Lefebvre J, Loeuille GA, Steinling M, Linquette M.
    Nouv Presse Med; 1979 Oct 08; 8(38):3033-6. PubMed ID: 534166
    [Abstract] [Full Text] [Related]

  • 5. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B, Reiner Z, Sekso M.
    Exp Clin Endocrinol; 1983 Jan 08; 81(1):41-8. PubMed ID: 6343098
    [Abstract] [Full Text] [Related]

  • 6. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD, Lantigua R, Lee LA.
    J Clin Endocrinol Metab; 1979 Sep 08; 49(3):326-30. PubMed ID: 468965
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB, Scott CL, Modebe O, Bethune JE.
    J Clin Endocrinol Metab; 1975 Feb 08; 40(2):256-9. PubMed ID: 1117978
    [Abstract] [Full Text] [Related]

  • 8. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F, Melluso K, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract] [Full Text] [Related]

  • 9. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb 30; 64(2):255-60. PubMed ID: 3793848
    [Abstract] [Full Text] [Related]

  • 10. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
    Felt V, Nedvdková J.
    Horm Metab Res; 1977 Jul 30; 9(4):274-7. PubMed ID: 408253
    [Abstract] [Full Text] [Related]

  • 11. L-dopa, growth hormone and adipokinesis in the lean and the obese.
    Pinter EJ, Tolis G, Friesen HG.
    Int J Clin Pharmacol Biopharm; 1975 Jul 30; 12(1-2):277-80. PubMed ID: 1165135
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G, Masala A, Alagna S, Devilla L, Lotti G.
    J Clin Endocrinol Metab; 1976 Dec 30; 43(6):1382-6. PubMed ID: 1002821
    [Abstract] [Full Text] [Related]

  • 13. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA, Hassing JM.
    J Clin Endocrinol Metab; 1984 Mar 30; 58(3):419-25. PubMed ID: 6420440
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D, Eckstein N, Avidan S, Eshel A, L'Hermite M, Caufriez A, Spitz I, Zylber-Haran E.
    Gynecol Obstet Invest; 1983 Mar 30; 16(2):97-106. PubMed ID: 6413305
    [Abstract] [Full Text] [Related]

  • 15. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE, Liuzzi A, Cocchi D, Panerai AE, Oppizzi G, Lacatelli V, Mantegazza P, Silvestrini F, Chiodini PG.
    Adv Biochem Psychopharmacol; 1977 Mar 30; 16():127-38. PubMed ID: 142419
    [No Abstract] [Full Text] [Related]

  • 16. [Growth hormone secretion after oral administration of L-dopa in primary hypothyroidism].
    Gembicki M, Sobieszczyk S, Kosowicz J.
    Endokrynol Pol; 1979 Mar 30; 30(2):155-61. PubMed ID: 467382
    [No Abstract] [Full Text] [Related]

  • 17. Bromocriptine: effect on serum prolactin and growth hormone in psychogeriatric hospital patients.
    Hontela S, Nair NP, Rosenberg G, Schwartz G, Guyda H.
    J Am Geriatr Soc; 1978 Feb 30; 26(2):49-52. PubMed ID: 627685
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ, Johnson RH, Keogh HJ, Nanda RN.
    J Neurol Neurosurg Psychiatry; 1978 Feb 30; 41(2):135-9. PubMed ID: 24678
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cimetidine-induced hyperprolactinaemia by pretreatment with levodopa or bromocriptine.
    Rolandi E, Masturzo P, Barreca T.
    Clin Endocrinol (Oxf); 1979 Jan 30; 10(1):93-5. PubMed ID: 436308
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
    Fang VS.
    Life Sci; 1981 May 11; 28(19):2143-9. PubMed ID: 7253807
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.